Nocturnal cortisol and melatonin secretion in primary insomnia. 2002

Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
Department of Psychiatry and Psychotherapy, University Hospital of Freiburg, Hauptstrasse 5, 79104, Freiburg, Germany. dieter_riemann@psyallg.ukl.uni-freiburg.de

The present study investigated evening and nocturnal serum cortisol and melatonin concentrations in patients with primary insomnia to test if this clinical condition is accompanied by an increase of cortisol secretion and a simultaneous decrease of nocturnal melatonin production. Ten drug-free patients (4 males, 6 females) with primary insomnia (mean age+/-S.D.: 39.2+/-9.1 years) and 10 age- and gender-matched healthy controls participated in the study. All subjects spent three consecutive nights in the sleep laboratory with polysomnography. Measurement of cortisol and melatonin (from 19:00 h to 09:00 h) was performed prior to and during the last laboratory night. Contrary to expectation, cortisol secretion did not differ between healthy controls and insomniac patients. On the other hand, nocturnal melatonin production was significantly diminished in insomniac patients. Polysomnographically determined sleep patterns, in contrast to subjective ratings of sleep, demonstrated only minor alterations of sleep in the insomniac group. The lack of increased cortisol secretion in the patients with primary insomnia indicates that results from studies on the biological consequences of experimental sleep loss in healthy subjects cannot be applied to primary insomnia in general, especially if there are only minor objective sleep alterations. In spite of the negligible objective sleep disturbances in the present sample, nocturnal melatonin production was reduced, which tentatively suggests a role for this hormone in primary insomniacs. The pathophysiological significance of this finding is, however, still a matter of debate.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D007319 Sleep Initiation and Maintenance Disorders Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition. Disorders of Initiating and Maintaining Sleep,Insomnia,Sleeplessness,Chronic Insomnia,DIMS (Disorders of Initiating and Maintaining Sleep),Early Awakening,Insomnia Disorder,Nonorganic Insomnia,Primary Insomnia,Psychophysiological Insomnia,Rebound Insomnia,Secondary Insomnia,Sleep Initiation Dysfunction,Transient Insomnia,Awakening, Early,Dysfunction, Sleep Initiation,Dysfunctions, Sleep Initiation,Insomnia Disorders,Insomnia, Chronic,Insomnia, Nonorganic,Insomnia, Primary,Insomnia, Psychophysiological,Insomnia, Rebound,Insomnia, Secondary,Insomnia, Transient,Insomnias,Sleep Initiation Dysfunctions
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000222 Adaptation, Physiological The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT. Adaptation, Physiologic,Adaptations, Physiologic,Adaptations, Physiological,Adaptive Plasticity,Phenotypic Plasticity,Physiological Adaptation,Physiologic Adaptation,Physiologic Adaptations,Physiological Adaptations,Plasticity, Adaptive,Plasticity, Phenotypic

Related Publications

Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
September 1996, Pharmacopsychiatry,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
January 1988, L'Encephale,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
May 2002, Neuroscience letters,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
October 1995, Journal of pineal research,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
January 2004, The Journal of neuropsychiatry and clinical neurosciences,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
January 1990, European archives of psychiatry and clinical neuroscience,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
December 1992, Psychiatry research,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
July 2009, Drug and therapeutics bulletin,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
October 1988, Neuroendocrinology,
Dieter Riemann, and Torsten Klein, and Andrea Rodenbeck, and Bernd Feige, and Andrea Horny, and Ruth Hummel, and Gesa Weske, and Anam Al-Shajlawi, and Ulrich Voderholzer
January 1987, Journal of pineal research,
Copied contents to your clipboard!